Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Vishwam Sankaran

FDA approves world’s first fast-acting nasal spray to treat migraines

PA Archive

The US Food and Drug Administration has approved a world-first fast-acting nasal spray to treat migraines, pharmaceutical giant Pfizer announced on Friday.

Pfizer noted in a statement that it expects the drug named Zavzpret to be available in pharmacies in July 2023.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.